Literature DB >> 17653644

Inflammatory myofibroblastic tumor of the liver.

Thomas Schnelldorfer1, Kenneth D Chavin, Angello Lin, David N Lewin, Prabhakar K Baliga.   

Abstract

Inflammatory myofibroblastic tumor is a rare benign entity formerly known as inflammatory pseudotumor. Involvement of the liver is extremely rare. There are controversies about the optimal treatment of this benign entity. Newer reports suggest an association with autoimmune sclerosing pancreatitis and primary sclerosing cholangitis. We present a case of an 18-year-old patient with biliary obstruction from a perihilar mass of the liver requiring hepatic resection. Division of the hepatic bile duct resulted in drainage of yellow, thick, gelatinous material in the presence of benign margins and absence of cholangitis. Histological examination showed a mass with fibroblastic and myofibroblastic cells set in a loose myxoid matrix containing scattered lymphocytes, consistent with an inflammatory myofibroblastic tumor. One-year recovery was uneventful. This report discusses the presentation, diagnosis, and controversies in management of this disease.

Entities:  

Mesh:

Year:  2007        PMID: 17653644     DOI: 10.1007/s00534-006-1176-3

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  3 in total

1.  Inflammatory angiomyolipoma of the liver: a rare hepatic tumor.

Authors:  Yang Liu; Jian Wang; Xu-Yong Lin; Hong-Tao Xu; Xue-shan Qiu; En-Hua Wang
Journal:  Diagn Pathol       Date:  2012-09-15       Impact factor: 2.644

2.  A case of multiple inflammatory hepatic pseudotumor protruding from the liver surface after colonic cancer.

Authors:  Toshikatsu Nitta; Jun Kataoka; Yoshihiro Inoue; Kensuke Fujii; Masahito Ohta; Hiroshi Kawasaki; Atsushi Takeshita; Takashi Ishibashi
Journal:  Int J Surg Case Rep       Date:  2017-06-08

3.  A Case of Inflammatory Pseudotumor of the Liver Mimicking Hepatocellular Carcinoma on EOB-MRI and PET.

Authors:  Hiroyoshi Iguchi; Hitoshi Yamazaki; Hidekazu Tsunoda; Yoshihito Takahashi; Hiroaki Yokomori
Journal:  Case Rep Med       Date:  2013-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.